GILD Long

AstrasZeneca deal or possible approvals of its Covid-19 drug Remdesivir may trigger the sharp increase to the upper bound of the daily trend.
SL below daily trend level.
Beyond Technical AnalysisFundamental AnalysisGILDTrend Analysis

Thông báo miễn trừ trách nhiệm